Inventor · disambiguated record
Bernd Hentsch
Also filed as: HENTSCH BERND
3 granted patents·19 pending applications·5 citations·filing 2001–2012
56Inventor score
Top patents by PatentIndex Score
22 records- 0173US8227516B2Compounds as histone deacetylase inhibitorsMAURER ALEXANDER B·Filed 2007·Granted Jul 24, 2012·5 cites·5 claims
- 0256US2007293579A1Use of carp inhibitors for the treatment of heart diseasesKLUXEN FRANZ-WERNER·Filed 2007·Application pending·0 cites
- 0348US2013231472A1Use of molecular markers for the preclinical profiling of inhibitors of enzymes having histone deacetylase activityHEINZEL THORSTEN·Filed 2012·Application pending·0 cites
- 0448US2009104182A1Inhibition of tristetraproline for protection of the heart from cardiac injuriesKLUXEN FRANZ-WERNER·Filed 2008·Application pending·0 cites
- 0548US2005074839A1Novel survivin interacting protein tpr1Filed 2002·Application pending·0 cites
- 0645US2004014706A1Use of carp inhibitors for the treatment of heart diseasesFiled 2001·Application pending·0 cites
- 0745US2006127937A1Novel Survivin interacting protein TPR1HENTSCH BERND·Filed 2006·Application pending·0 cites
- 0842US7892833B2Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditionsTOPOTARGET GERMANY AG·Filed 2005·Granted Feb 22, 2011·0 cites·13 claims
- 0942US2006110735A1Use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activityHEINZEL THORSTEN·Filed 2003·Application pending·0 cites
- 1039US7166701B2Human survivin interacting protein 1 (SIP-1)MERCK PATENT GMBH·Filed 2001·Granted Jan 23, 2007·0 cites·13 claims
- 1137US2005084860A1Inhibition of tristetraproline for protection of the heart from cardiac injuriesFiled 2002·Application pending·0 cites
- 1237US2009186809A1Use of valproic acid for the topical treatment of mild to moderate acne vulgarisTOPOTARGET GERMANY AG·Filed 2007·Application pending·0 cites
- 1336US2008181894A1Identification of Human Gene Sequences of Cancer Antigens Expressed in Metastatic Carcinoma Involved in Metastasis Formation, and Their Use in Cancer Diagnosis, Prognosis and TherapyMINK SIGRUN·Filed 2006·Application pending·0 cites
- 1435US2005038113A1Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual diseaseG2M CANCER DRUGS AG·Filed 2002·Application pending·0 cites
- 1534US2004039166A1Iapl-3 a novel protein inhibitor of apoptosis proteinFiled 2001·Application pending·0 cites
- 1634US2004039185A1Novel family member of inhibitor of apoptosis proteinsFiled 2001·Application pending·0 cites
- 1734US2005176686A1Novel compounds as histone deacetylase inhibitorsG2M CANCER DRUGS AG·Filed 2003·Application pending·0 cites
- 1833US2004072999A1Novel protein inhibitor of apoptosis proteinsFiled 2001·Application pending·0 cites
- 1933US2005058647A1Phosphodiesterase type 7bFiled 2001·Application pending·0 cites
- 2031US2006252157A1Larynx carcinoma-associated protein larcap-1DUCKER KLAUS·Filed 2001·Application pending·0 cites
- 2131US2008207724A1Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human DiseasesMINK SIGRUN·Filed 2006·Application pending·0 cites
- 2227US2011092447A1Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditionsHENTSCH BERND·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bernd Hentsch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →